中华生物医学工程杂志
中華生物醫學工程雜誌
중화생물의학공정잡지
CHINESE JOURNAL OF BIOMEDICAL ENGINEERING
2009年
6期
486-489
,共4页
张蓉%李传行%单宏波%高小燕%罗广裕%林世永%李茵%徐国良
張蓉%李傳行%單宏波%高小燕%囉廣裕%林世永%李茵%徐國良
장용%리전행%단굉파%고소연%라엄유%림세영%리인%서국량
腔内超声检查%平滑肌瘤%食管镜检查%内镜黏膜切除术%内镜黏膜下剥离术
腔內超聲檢查%平滑肌瘤%食管鏡檢查%內鏡黏膜切除術%內鏡黏膜下剝離術
강내초성검사%평활기류%식관경검사%내경점막절제술%내경점막하박리술
Endosonography%Leiomyoma%Esophagoscopy%Endoscopic mucnsal resection%Endoscopic submucosal dissection
目的 评价超声内镜对食管平滑肌瘤的诊断及治疗中的价值.探讨内镜黏膜切除术(EMR)、内镜黏膜下剥离术(ESD)治疗食管平滑肌瘤的疗效和安全性.方法 对内镜检查中发现的40例食管黏膜下肿瘤行超声内镜检查,其中30例为起源于黏膜肌层的食管平滑肌瘤,4例为起源于同有肌层的食管平滑肌瘤.对30例起源于黏膜肌层的食管平滑肌瘤,根据病变大小决定行内镜下EMR或ESD治疗,完整切除病变.对4例起源于固有肌层的食管平滑肌瘤,考虑穿孔可能性大,未予内镜下治疗.结果 40例食管黏膜下肿瘤,病变直径0.4~2.5 cm(中位直径1.45 cm).24例行内镜下EMR治疗,6例病变直径超过1.5 cm行内镜下ESD治疗,ESD手术时间15~45 min(中位时间30min).2例术中出血较多.经内镜喷洒止血药物、电凝、氩离子束凝固治疗及金属钛夹钳夹止血,无术后出血,无ESD穿孔.所有EMR或ESD切除病变送检病理确诊,基底和切缘未见病变累及.术后1.5个月及6个月随访,创面愈合,无病变残留和复发.结论 超声内镜能够准确地诊断食管平滑肌瘤并指导其治疗.大多数食管平滑肌瘤的EMR治疗是简便和安全的.对于病灶较大、EMR难以完整切除的病变可行ESD治疗,也是安伞有效的,它可以完整切除食管病变,并提供完整的病理诊断资料.
目的 評價超聲內鏡對食管平滑肌瘤的診斷及治療中的價值.探討內鏡黏膜切除術(EMR)、內鏡黏膜下剝離術(ESD)治療食管平滑肌瘤的療效和安全性.方法 對內鏡檢查中髮現的40例食管黏膜下腫瘤行超聲內鏡檢查,其中30例為起源于黏膜肌層的食管平滑肌瘤,4例為起源于同有肌層的食管平滑肌瘤.對30例起源于黏膜肌層的食管平滑肌瘤,根據病變大小決定行內鏡下EMR或ESD治療,完整切除病變.對4例起源于固有肌層的食管平滑肌瘤,攷慮穿孔可能性大,未予內鏡下治療.結果 40例食管黏膜下腫瘤,病變直徑0.4~2.5 cm(中位直徑1.45 cm).24例行內鏡下EMR治療,6例病變直徑超過1.5 cm行內鏡下ESD治療,ESD手術時間15~45 min(中位時間30min).2例術中齣血較多.經內鏡噴灑止血藥物、電凝、氬離子束凝固治療及金屬鈦夾鉗夾止血,無術後齣血,無ESD穿孔.所有EMR或ESD切除病變送檢病理確診,基底和切緣未見病變纍及.術後1.5箇月及6箇月隨訪,創麵愈閤,無病變殘留和複髮.結論 超聲內鏡能夠準確地診斷食管平滑肌瘤併指導其治療.大多數食管平滑肌瘤的EMR治療是簡便和安全的.對于病竈較大、EMR難以完整切除的病變可行ESD治療,也是安傘有效的,它可以完整切除食管病變,併提供完整的病理診斷資料.
목적 평개초성내경대식관평활기류적진단급치료중적개치.탐토내경점막절제술(EMR)、내경점막하박리술(ESD)치료식관평활기류적료효화안전성.방법 대내경검사중발현적40례식관점막하종류행초성내경검사,기중30례위기원우점막기층적식관평활기류,4례위기원우동유기층적식관평활기류.대30례기원우점막기층적식관평활기류,근거병변대소결정행내경하EMR혹ESD치료,완정절제병변.대4례기원우고유기층적식관평활기류,고필천공가능성대,미여내경하치료.결과 40례식관점막하종류,병변직경0.4~2.5 cm(중위직경1.45 cm).24례행내경하EMR치료,6례병변직경초과1.5 cm행내경하ESD치료,ESD수술시간15~45 min(중위시간30min).2례술중출혈교다.경내경분쇄지혈약물、전응、아리자속응고치료급금속태협겸협지혈,무술후출혈,무ESD천공.소유EMR혹ESD절제병변송검병리학진,기저화절연미견병변루급.술후1.5개월급6개월수방,창면유합,무병변잔류화복발.결론 초성내경능구준학지진단식관평활기류병지도기치료.대다수식관평활기류적EMR치료시간편화안전적.대우병조교대、EMR난이완정절제적병변가행ESD치료,야시안산유효적,타가이완정절제식관병변,병제공완정적병리진단자료.
Objective To evaluate the diagnostic value of endoscopic ultrasonography (EUS) and endoscopic therapies in esophageal leiomyoma under the guidance of EUS, and to assess the clinical efficacy and safety of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for esophageal leiomyoma.Methods A total of 40 patients with submucosal tumors (SMT) of the esophagus diagnosed by endoscopy were examined by EUS.Of these patients, esophageal ieiomyoma was found deriving from muscularis mucosa in 30 and from proper muscle layer in 4.All muscularis mucosa-derived lesions were completely removed with EMR or ESD depending on tumor size, while the proper muscle layer- derived lesions did not receive endoscopic surgery due to a higher risk of esophageal perforation.Results The resected SMT sized 0.4-2.5 cm in diameter (mediam: 1.45 cm).Among the 40 lesions, 24 were successfully resected by EMR and 6 with diameter over 1.5 cm were resected by ESD.The mediam ESD procedure time was 30 rain (range 15 to 45 min).Two patients had massive hemorrhage during ESD, which could be controlled under gastroscopic spray of hemostatie agents, electric cautery, argon plasma coaqulation and titanic clip placement.None of the patients had delayed bleeding or perforation after ESD.Histological evaluation showed that the tunica of the tumors was intact, and beth the lateral and basal margins of the specimens were free of tumor cells.Follow-up at 1.5 and 6 months after ESD healing of artificial ulcer was confirmed with no residue or recurrence.Conclusions Esophageal leiomyoma can be definitely diagnosed by EUS and subjected to EUS-guided treatment.Most of esophageal leiomyoma may be resected simply and safely by EMR.For larger lesions that may be difficult to resect completely with EMR, ESD can be a safe and effective substitute, which yielded not only complete removal, but also complete information for pathological study.